LeonaBio, Inc. (LONA)
NASDAQ: LONA · Real-Time Price · USD
8.69
+0.34 (4.07%)
Apr 28, 2026, 4:00 PM EDT - Market closed
LeonaBio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 16.68 | 26.09 | 33.3 | 32.55 | 21.23 | |
| Research & Development | 17.5 | 70.68 | 93.79 | 61.46 | 42.79 | |
| Operating Expenses | 34.18 | 96.78 | 127.09 | 94.02 | 64.02 | |
| Operating Income | -34.18 | -96.78 | -127.09 | -94.02 | -64.02 | |
| Other Non Operating Income (Expenses) | -3.67 | 3.45 | 6.38 | 7.96 | 9.17 | |
| EBT Excluding Unusual Items | -37.85 | -93.33 | -120.71 | -86.06 | -54.85 | |
| Gain (Loss) on Sale of Investments | 0.33 | 0.52 | 1.41 | 0.42 | - | |
| Legal Settlements | - | -4.13 | - | -10 | - | |
| Pretax Income | -105.61 | -96.94 | -117.67 | -95.64 | -54.85 | |
| Net Income | -105.61 | -96.94 | -117.67 | -95.64 | -54.85 | |
| Net Income to Common | -105.61 | -96.94 | -117.67 | -95.64 | -54.85 | |
| Shares Outstanding (Basic) | 4 | 4 | 4 | 4 | 4 | |
| Shares Outstanding (Diluted) | 4 | 4 | 4 | 4 | 4 | |
| Shares Change (YoY) | 11.12% | 1.21% | 0.76% | 2.20% | 208.53% | |
| EPS (Basic) | -24.70 | -25.19 | -30.95 | -25.35 | -14.86 | |
| EPS (Diluted) | -24.70 | -25.19 | -30.95 | -25.35 | -14.86 | |
| Free Cash Flow | -45.73 | -97.2 | -101.06 | -73.61 | -44.67 | |
| Free Cash Flow Per Share | -10.70 | -25.26 | -26.58 | -19.51 | -12.10 | |
| EBITDA | -33.21 | -95.81 | -126.13 | -93.17 | -63.54 | |
| D&A For EBITDA | 0.97 | 0.97 | 0.97 | 0.85 | 0.48 | |
| EBIT | -34.18 | -96.78 | -127.09 | -94.02 | -64.02 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.